Trupanion (TRUP)
(Delayed Data from NSDQ)
$31.30 USD
+0.93 (3.06%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $31.25 -0.05 (-0.16%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$31.30 USD
+0.93 (3.06%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $31.25 -0.05 (-0.16%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum C VGM
Zacks News
East West Bancorp (EWBC) Misses Q4 Earnings Estimates
by Zacks Equity Research
East West Bancorp (EWBC) delivered earnings and revenue surprises of -1.94% and 1.85%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KIE
Here's Why You Should Stay Invested in Trupanion (TRUP)
by Zacks Equity Research
Trupanion (TRUP) is poised for growth in a total addressable market of $34.1 billion, given a change in the attitude of pet owners, who are increasingly focusing on pets' health and well-being.
Should You Invest in the SPDR S&P Insurance ETF (KIE)?
by Zacks Equity Research
Sector ETF report for KIE
Trupanion (TRUP) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of 77.78% and 2.02%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Should You Invest in the SPDR S&P Insurance ETF (KIE)?
by Zacks Equity Research
Sector ETF report for KIE
Trupanion (TRUP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Offing for Unum Group (UNM) in Q3 Earnings?
by Zacks Equity Research
Unum Group (UNM) Q3 is likely to benefit from better results at its Unum U.S and Colonial Life segments.
Why Should You Hold Onto the Pet Insurer Trupanion (TRUP)?
by Zacks Equity Research
Trupanion's (TRUP) long-term growth strategy and the burgeoning pet insurance market make it a stock to hold onto for netting solid long-term gains.
Trupanion (TRUP) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of 52.94% and 1.96%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Trupanion (TRUP) Q2 Earnings Expected to Decline
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife (MET) Launches Pet Insurance Product, Boosts Portfolio
by Zacks Equity Research
MetLife (MET) introduces a pet insurance product, which intends to offer enhanced care for pets and address financial stress of pet parents.
Moving Average Crossover Alert: Trupanion (TRUP)
by Zacks Equity Research
Trupanion (TRUP) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Trupanion (TRUP) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of -25.00% and 1.91%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Aflac (AFL) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Aflac's (AFL) first-quarter results are likely to reflect higher adjusted net investment income and cost-curbing efforts, partly offset by weaker sales.
Trupanion (TRUP) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Trupanion (TRUP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion (TRUP) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of -200.00% and 2.45%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Trupanion (TRUP) Q4 Earnings Expected to Decline
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion (TRUP) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of -75.00% and 2.65%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Trupanion (TRUP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trupanion (TRUP) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Trupanion (TRUP) delivered earnings and revenue surprises of 500.00% and 2.72%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Retain Brown & Brown in Your Portfolio
by Zacks Equity Research
Brown & Brown (BRO) is poised to benefit from constant top-line growth and solid cash flow generating abilities.
Dull Near-Term Prospects for Accident & Health Insurance
by Tanuka De
Accident and Health Insurance industry should see new sales getting affected while frequency of claims from essential service industries are bound to rise.
Why Trupanion (TRUP) Might Surprise This Earnings Season
by Zacks Equity Research
Trupanion (TRUP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season
Zacks.com featured highlights include: MagnaChip Semiconductor, International Money Express, USANA Health Sciences and Trupanion
by Zacks Equity Research
Zacks.com featured highlights include: MagnaChip Semiconductor, International Money Express, USANA Health Sciences and Trupanion